Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
作者信息
Kalliolias George D, Georgiou Panagiotis E, Antonopoulos Ioannis A, Andonopoulos Andrew P, Liossis Stamatis-Nick C
出版信息
Ann Rheum Dis. 2007 Jun;66(6):842-3. doi: 10.1136/ard.2006.066381.
Abstract
摘要
相似文献
1
Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.阿那白滞素治疗成人斯蒂尔病患者起效快、疗效好、安全性高且可减少类固醇用量：一项非对照试验的经验
Ann Rheum Dis. 2007 Jun;66(6):842-3. doi: 10.1136/ard.2006.066381.
2
Adult-onset Still's disease in a patient with cystic fibrosis and its successful treatment with anakinra.一名囊性纤维化患者患成人斯蒂尔病及其用阿那白滞素成功治疗的病例
Rheumatology (Oxford). 2012 Sep;51(9):1730-2. doi: 10.1093/rheumatology/kes040. Epub 2012 Apr 17.
3
Effective treatment of steroid refractory adult-onset Still's disease with anakinra.阿那白滞素有效治疗类固醇难治性成人斯蒂尔病。
J Rheumatol. 2008 May;35(5):939-41.
4
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease.白细胞介素1受体拮抗剂阿那白滞素在治疗难治性成人斯蒂尔病中具有持久疗效。
Ann Rheum Dis. 2010 Feb;69(2):466-7. doi: 10.1136/ard.2009.108068.
5
Early use of anakinra in adult-onset Still's disease myocarditis.阿那白滞素在成人斯蒂尔病性心肌炎中的早期应用。
Scand J Rheumatol. 2018 Nov;47(6):511-512. doi: 10.1080/03009742.2017.1387672. Epub 2018 Jan 2.
6
Anakinra in children and adults with Still's disease.阿那白滞素在儿童和成人斯蒂尔病中的应用。
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi9-vi22. doi: 10.1093/rheumatology/kez350.
7
Marked effect and steroid-sparing ability of anakinra on a patient with refractory adult-onset Still's disease.阿那白滞素治疗难治性成人Still 病的显著疗效和激素节省作用。
Mod Rheumatol. 2010 Apr;20(2):200-4. doi: 10.1007/s10165-009-0254-1.
8
Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra.成人斯蒂尔病合并心肌炎经白细胞介素-1受体拮抗剂阿那白滞素成功治疗。
Joint Bone Spine. 2011 Jan;78(1):100-1. doi: 10.1016/j.jbspin.2010.09.014. Epub 2010 Oct 30.
9
Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.阿那白滞素在一名因成人斯蒂尔病接受肝移植患者中的长期疗效及安全性
Mod Rheumatol. 2014 Nov;24(6):1030-1. doi: 10.3109/14397595.2013.854437. Epub 2013 Dec 6.
10
Efficacy of anakinra in a case of refractory Still disease.
J Clin Rheumatol. 2008 Dec;14(6):357-8. doi: 10.1097/RHU.0b013e318188b8d8.
引用本文的文献
1
Anakinra in the management of adult-onset still's disease: a single-center experience.阿那白滞素治疗成人斯蒂尔病：单中心经验
Intern Emerg Med. 2025 Jan;20(1):131-138. doi: 10.1007/s11739-024-03766-6. Epub 2024 Sep 16.
2
The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation.白细胞介素-1在围产期炎症中的作用及其对过渡循环的影响。
Front Pediatr. 2023 Mar 13;11:1130013. doi: 10.3389/fped.2023.1130013. eCollection 2023.
3
The Role of the Interleukin-1 Family in Complications of Prematurity.白细胞介素-1 家族在早产儿并发症中的作用。
Int J Mol Sci. 2023 Feb 1;24(3):2795. doi: 10.3390/ijms24032795.
4
Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still's disease.采用阿那白滞素成功治疗成人Still 病患者的间质性肺炎。
Eur J Hosp Pharm. 2021 Nov;28(6):346-349. doi: 10.1136/ejhpharm-2020-002377. Epub 2020 Aug 11.
5
Management of adult-onset Still's disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts.成人斯蒂尔病的白细胞介素-1 抑制剂治疗：意大利专家组基于循证和共识的建议声明。
Arthritis Res Ther. 2019 Dec 11;21(1):275. doi: 10.1186/s13075-019-2021-9.
6
Autoinflammatory Pathogenesis and Targeted Therapy for Adult-Onset Still's Disease.成人斯蒂尔病的自身炎症发病机制和靶向治疗。
Clin Rev Allergy Immunol. 2020 Feb;58(1):71-81. doi: 10.1007/s12016-019-08747-8.
7
Mechanisms, biomarkers and targets for adult-onset Still's disease.成人Still 病的发病机制、生物标志物和靶点。
Nat Rev Rheumatol. 2018 Oct;14(10):603-618. doi: 10.1038/s41584-018-0081-x.
8
Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.成人Still 病：分子病理生理学和治疗进展。
Drugs. 2018 Aug;78(12):1187-1195. doi: 10.1007/s40265-018-0956-9.
9
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients.成人起病型斯蒂尔病：一项针对245例患者的临床表现及治疗的意大利多中心回顾性观察研究。
Clin Rheumatol. 2016 Jul;35(7):1683-9. doi: 10.1007/s10067-016-3308-8. Epub 2016 May 20.
10
A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?一项关于成人斯蒂尔病患者的回顾性研究：心包炎是否是生物性改善病情抗风湿药物需求的可能预测指标？
Clin Rheumatol. 2016 Aug;35(8):2117-2123. doi: 10.1007/s10067-015-3164-y. Epub 2016 Jan 12.
本文引用的文献
1
Refractory adult onset Still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors: are biological agents the solution?难治性成人斯蒂尔病及对非甾体抗炎药和环氧化酶-2抑制剂的超敏反应：生物制剂是解决办法吗？
Ann Rheum Dis. 2005 Oct;64(10):1523-4. doi: 10.1136/ard.2005.042945. Epub 2005 Jul 13.
2
Rapid responses to anakinra in patients with refractory adult-onset Still's disease.难治性成人斯蒂尔病患者对阿那白滞素的快速反应。
Arthritis Rheum. 2005 Jun;52(6):1794-803. doi: 10.1002/art.21061.
3
Blocking IL-1 in systemic inflammation.在全身炎症中阻断白细胞介素-1
J Exp Med. 2005 May 2;201(9):1355-9. doi: 10.1084/jem.20050640.
4
Refractory adult onset Still's disease successfully treated with anakinra.用阿那白滞素成功治疗难治性成人斯蒂尔病。
Ann Rheum Dis. 2005 Apr;64(4):647-8. doi: 10.1136/ard.2004.026617. Epub 2004 Sep 16.
5
Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.肿瘤坏死因子α阻断剂治疗难治性成人斯蒂尔病：一项20例的观察性研究
Ann Rheum Dis. 2005 Feb;64(2):262-6. doi: 10.1136/ard.2004.024026. Epub 2004 Jun 7.
6
Adult Still's disease: review of 228 cases from the literature.成人斯蒂尔病：文献中228例病例的综述
J Rheumatol. 1987 Dec;14(6):1139-46.
7
Preliminary criteria for classification of adult Still's disease.成人斯蒂尔病的初步分类标准。
J Rheumatol. 1992 Mar;19(3):424-30.
Zotero 插件